Jianjiang Fu - Search Results

Year	Number of Results
2006	2
2007	3
2008	1
2009	1
2011	1
2012	1
2014	4
2015	4
2016	1
2017	2
2018	4
2020	1
2021	3
2022	2
2023	2
2024	1

1

Wang N, Fu J, Li Z, Jiang N, Chen Y, Peng J. Wang N, et al. Among authors: fu j. Cancers (Basel). 2022 Feb 5;14(3):811. doi: 10.3390/cancers14030811. Cancers (Basel). 2022. PMID: 35159078 Free PMC article. Review.

2

Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicine.

Lai B, Fu J, Zhang Q, Deng N, Jiang Q, Peng J. Lai B, et al. Among authors: fu j. Int J Oncol. 2023 Sep;63(3):107. doi: 10.3892/ijo.2023.5555. Epub 2023 Aug 4. Int J Oncol. 2023. PMID: 37539741 Review.

3

HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence.

Fu J, Su X, Li Z, Deng L, Liu X, Feng X, Peng J. Fu J, et al. Oncogene. 2021 Jul;40(28):4625-4651. doi: 10.1038/s41388-021-01863-w. Epub 2021 Jun 18. Oncogene. 2021. PMID: 34145400 Review.

4

Sesquiterpenoids from the leaves of Chimonanthus nitens.

Guo N, Shu QB, Dong YL, Fu JJ, Shu RG. Guo N, et al. J Asian Nat Prod Res. 2023 Jan;25(1):53-60. doi: 10.1080/10286020.2022.2058932. Epub 2022 Apr 21. J Asian Nat Prod Res. 2023. PMID: 35446749

5

Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.

Jiang N, Dai Q, Su X, Fu J, Feng X, Peng J. Jiang N, et al. Among authors: fu j. Mol Biol Rep. 2020 Jun;47(6):4587-4629. doi: 10.1007/s11033-020-05435-1. Epub 2020 Apr 24. Mol Biol Rep. 2020. PMID: 32333246 Free PMC article. Review.

6

Transcriptomic signatures in breast cancer.

Fu J, Jeffrey SS. Fu J, et al. Mol Biosyst. 2007 Jul;3(7):466-72. doi: 10.1039/b618163e. Epub 2007 Jun 5. Mol Biosyst. 2007. PMID: 17579771 Review.

7

Six new cadinane-type sesquiterpenoids from the leaves of Chimonanthus nitens Oliv.

Guo N, Shu QB, Zhang PY, Fu JJ, Wan YL, Wang XM, Shu RG. Guo N, et al. Fitoterapia. 2021 Oct;154:105019. doi: 10.1016/j.fitote.2021.105019. Epub 2021 Aug 14. Fitoterapia. 2021. PMID: 34403777

8

The natural compound codonolactone attenuates TGF-β1-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells.

Fu J, Ke X, Tan S, Liu T, Wang S, Ma J, Lu H. Fu J, et al. Oncol Rep. 2016 Jan;35(1):117-26. doi: 10.3892/or.2015.4394. Epub 2015 Nov 4. Oncol Rep. 2016. PMID: 26549400

9

In vitro anti-motile effects of Rhoifolin, a flavonoid extracted from Callicarpa nudiflora on breast cancer cells via downregulating Podocalyxin-Ezrin interaction during Epithelial Mesenchymal Transition.

Xiong L, Lu H, Hu Y, Wang W, Liu R, Wan X, Fu J. Xiong L, et al. Among authors: fu j. Phytomedicine. 2021 Dec;93:153486. doi: 10.1016/j.phymed.2021.153486. Epub 2021 Jan 28. Phytomedicine. 2021. PMID: 34649211

10

Inhibitory effects of luteolin‑4'‑O‑β‑D‑glucopyranoside on P2Y12 and thromboxane A2 receptor‑mediated amplification of platelet activation in vitro.

Xu H, Lu H, Zhu X, Wang W, Zhang Z, Fu H, Ma S, Luo Y, Fu J. Xu H, et al. Among authors: fu j. Int J Mol Med. 2018 Jul;42(1):615-624. doi: 10.3892/ijmm.2018.3634. Epub 2018 Apr 19. Int J Mol Med. 2018. PMID: 29693158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

28 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year